Literature DB >> 11353606

Molecular basis of rifampin and isoniazid resistance in Mycobacterium bovis strains isolated in Sardinia, Italy.

L A Sechi1, S Zanetti, M Sanguinetti, P Molicotti, L Romano, G Leori, G Delogu, S Boccia, M La Sorda, G Fadda.   

Abstract

Fourteen of 22 (68%) Mycobacterium bovis strains isolated from cattle in Sardinia were found to be resistant to rifampin and isoniazid. Analysis of the rpoB and the katG, oxyR-ahpC, and inhA gene regions of these strains was performed in order to investigate the molecular basis of rifampin and isoniazid resistance, respectively. The most frequent mutation, encountered in 6 of 10 strains (60%), was in the rpoB gene; it occurred, at codon position 521 and resulted in leucine changed to proline. This suggests that codon 521 may be important for the development of rifampin resistance in M. bovis. Resistance to isoniazid is associated in Mycobacterium tuberculosis with a variety of mutations affecting one or more genes. Our results confirm the difficulty of interpreting the sequence variations observed in clinical strains of M. bovis. M. bovis strains isolated from the same geographic area showed similar mutations within the genes responsible for rifampin and isoniazid resistance. Our results represent the first study to elucidate the molecular genetic basis of drug resistance in M. bovis isolated from cattle.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11353606      PMCID: PMC90526          DOI: 10.1128/AAC.45.6.1645-1648.2001

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  20 in total

1.  Different strategies for molecular differentiation of Mycobacterium bovis strains isolated in Sardinia, Italy.

Authors:  L A Sechi; G Leori; S A Lollai; I Duprè; P Molicotti; G Fadda; S Zanetti
Journal:  Appl Environ Microbiol       Date:  1999-04       Impact factor: 4.792

2.  Detection of Mycobacterium tuberculosis complex in lymph nodes of wild boar (Sus scrofa) by a target-amplified test system.

Authors:  E Bollo; E Ferroglio; V Dini; W Mignone; B Biolatti; L Rossi
Journal:  J Vet Med B Infect Dis Vet Public Health       Date:  2000-06

3.  Missense mutations in the catalase-peroxidase gene, katG, are associated with isoniazid resistance in Mycobacterium tuberculosis.

Authors:  B Heym; P M Alzari; N Honoré; S T Cole
Journal:  Mol Microbiol       Date:  1995-01       Impact factor: 3.501

4.  Molecular mechanisms of multiple drug resistance in clinical isolates of Mycobacterium tuberculosis.

Authors:  S Morris; G H Bai; P Suffys; L Portillo-Gomez; M Fairchok; D Rouse
Journal:  J Infect Dis       Date:  1995-04       Impact factor: 5.226

5.  A Ser315Thr substitution in KatG is predominant in genetically heterogeneous multidrug-resistant Mycobacterium tuberculosis isolates originating from the St. Petersburg area in Russia.

Authors:  H J Marttila; H Soini; E Eerola; E Vyshnevskaya; B I Vyshnevskiy; T F Otten; A V Vasilyef; M K Viljanen
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

6.  Geographic distribution of restriction types of Mycobacterium bovis isolates from brush-tailed possums (Trichosurus vulpecula) in New Zealand.

Authors:  D M Collins; G W De Lisle; D M Gabric
Journal:  J Hyg (Lond)       Date:  1986-06

7.  Application of molecular methods for detection and transmission analysis of mycobacterium tuberculosis drug resistance in patients attending a reference hospital in Italy.

Authors:  A Cingolani; A Antinori; M Sanguinetti; L Gillini; A De Luca; B Posteraro; F Ardito; G Fadda; L Ortona
Journal:  J Infect Dis       Date:  1999-04       Impact factor: 5.226

8.  Recovery and susceptibility testing of Mycobacterium tuberculosis from extrapulmonary specimens by the BACTEC radiometric method.

Authors:  G Fadda; S L Roe
Journal:  J Clin Microbiol       Date:  1984-05       Impact factor: 5.948

9.  Implications of multidrug resistance for the future of short-course chemotherapy of tuberculosis: a molecular study.

Authors:  B Heym; N Honoré; C Truffot-Pernot; A Banerjee; C Schurra; W R Jacobs; J D van Embden; J H Grosset; S T Cole
Journal:  Lancet       Date:  1994-07-30       Impact factor: 79.321

10.  The occurrence of Mycobacterium bovis infection in cattle in and around an area subject to extensive badger (Meles meles) control.

Authors:  R S Clifton-Hadley; J W Wilesmith; M S Richards; P Upton; S Johnston
Journal:  Epidemiol Infect       Date:  1995-02       Impact factor: 2.451

View more
  5 in total

1.  Use of DNA extracts from Ziehl-Neelsen-stained slides for molecular detection of rifampin resistance and spoligotyping of Mycobacterium tuberculosis.

Authors:  A G M Van Der Zanden; E M Te Koppele-Vije; N Vijaya Bhanu; D Van Soolingen; L M Schouls
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

2.  Use of the hupB gene encoding a histone-like protein of Mycobacterium tuberculosis as a target for detection and differentiation of M. tuberculosis and M. bovis.

Authors:  S Prabhakar; A Mishra; A Singhal; V M Katoch; S S Thakral; J S Tyagi; H K Prasad
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

3.  Molecular detection and drug resistance of Mycobacterium tuberculosis complex from cattle at a dairy farm in the Nkonkobe region of South Africa: a pilot study.

Authors:  Blessing Silaigwana; Ezekiel Green; Roland N Ndip
Journal:  Int J Environ Res Public Health       Date:  2012-05-29       Impact factor: 3.390

4.  Detection of a streptomycin-resistant Mycobacterium bovis strain through antitubercular drug susceptibility testing of Tunisian Mycobacterium tuberculosis complex isolates from cattle.

Authors:  Saif Eddine Djemal; Cristina Camperio; Federica Armas; Mariam Siala; Salma Smaoui; Feriele Messadi-Akrout; Radhouane Gdoura; Cinzia Marianelli
Journal:  BMC Vet Res       Date:  2018-09-29       Impact factor: 2.741

5.  Identification of drug resistance mutations among Mycobacterium bovis lineages in the Americas.

Authors:  Carlos Arturo Vázquez-Chacón; Felipe de Jesús Rodríguez-Gaxiola; Cruz Fernando López-Carrera; Mayra Cruz-Rivera; Armando Martínez-Guarneros; Ricardo Parra-Unda; Eliakym Arámbula-Meraz; Salvador Fonseca-Coronado; Gilberto Vaughan; Paúl Alexis López-Durán
Journal:  PLoS Negl Trop Dis       Date:  2021-02-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.